R(-)-N-Allylnorapomorphine is primarily used in research settings to study dopamine receptor activity in the brain. It acts as a dopamine agonist, making it valuable for exploring the mechanisms of dopamine-related neurological disorders such as Parkinson's disease and schizophrenia. Its ability to bind to dopamine receptors helps researchers understand receptor function and develop potential therapeutic agents. Additionally, it has been used in behavioral studies to investigate the role of dopamine in motor control and reward systems. Its applications are largely confined to experimental and preclinical studies rather than clinical or industrial use.